about
Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trialgp91phox-dependent expression of platelet CD40 ligandPreclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome.Cutaneous granulomatosis and combined immunodeficiency revealing Ataxia-Telangiectasia: a case reportA randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia.Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.Different degrees of NADPH oxidase 2 regulation and in vivo platelet activation: lesson from chronic granulomatous diseaseSubcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter study.Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis.X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.Lack of iNKT cells in patients with combined immune deficiency due to hypomorphic RAG mutationsChronic granulomatous disease presenting with salmonella brain abscesses.How should eosinophilic cystitis be treated in patients with chronic granulomatous disease?Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.Familial hemophagocytic lymphohistiocytosis type 3 diagnosed at school age: a case report.A 2-month-old male with pyuria and persistent fever.Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency.Immunization status of internationally adopted children in Rome, Italy.Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease.Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID.Clinical features and follow-up in patients with 22q11.2 deletion syndrome.Etiology, clinical outcome, and laboratory features in children with neutropenia: analysis of 104 cases.Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study.HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders.Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.Non invasive assessment of lung disease in ataxia telangiectasia by high-field magnetic resonance imaging.Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function.Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA).Fulminant Fusobacterium necrophorum meningitis in an immunocompetent adolescent.Evaluation of the relevance of humoral immunodeficiencies in a pediatric population affected by recurrent infections.Evidence of clonotypic pattern of T-cell repertoire in synovial fluid of children with juvenile rheumatoid arthritis at the onset of the disease.Consanguinity and polygenic diseases: a model for antibody deficienciesImmunodeficiency in Vici syndrome: A heterogeneous phenotypeDoes NADPH Oxidase Deficiency Cause Artery Dilatation in Humans?Reduced Atherosclerotic Burden in Subjects With Genetically Determined Low Oxidative StressInherited Human gp91 phox Deficiency Is Associated With Impaired Isoprostane Formation and Platelet DysfunctionNox2 Is Determinant for Ischemia-Induced Oxidative Stress and Arterial Vasodilatation: A Pilot Study in Patients With Hereditary Nox2 DeficiencySerratia marcescens Osteomyelitis in a Newborn with Chronic Granulomatous DiseaseTransitory hypogammaglobulinemia of infancy in FG syndromeSuccessful Treatment With Percutaneous Transhepatic Alcoholization of a Liver Abscess in a Child With Chronic Granulomatous Disease
P50
Q27498979-6798D149-A639-4F88-8058-03BCCD1FCC9DQ28208601-1C875A9E-4586-4EE5-A246-F3098862734CQ33399943-3C50892D-2046-48C8-9BA6-14DDDA02B617Q33803256-C0BC1E96-0482-4B68-BD61-3364061234AAQ34296348-5330E329-E0E0-4129-B443-5665A0CCF547Q34356904-155DB738-4622-4955-BCD8-EBF0FD5EC833Q35021974-D95D5217-291E-4EDF-B1E3-AF1850F3B16DQ35103593-003B2F21-7586-46E7-A64B-BA0BFA18378BQ35618854-9B8D907B-8EEB-401C-B2BE-7A8C42F102DEQ36030027-DA7C271E-9A52-4027-A51E-424E0194019DQ36384624-1E5E1DC5-3992-4EB1-B3D6-FA589D16DEF9Q38180377-0F2F8B11-5AF3-47FE-9AD5-DAB28DA070BFQ38231136-1DDB800A-57EF-4106-96A7-461A12EC0C01Q38672968-5AE7FBEC-CF72-4606-94D6-9814CE624B91Q40247949-1E226B78-079E-4C1A-8C80-2F594EA89D3AQ40271859-EAB433E2-7AF4-478E-8C3B-C65F52EF9DF0Q41070585-B230A937-CE0D-4DE0-9BEC-3E874DB78656Q41218763-27909F9C-4BFA-4DED-94D0-CC220263377CQ41759752-94923CDC-4F80-40EC-9C07-03E180947031Q42164387-73F1AE9C-D801-47CA-AA95-0C5B8FD62693Q42222753-D3C523F7-36DB-4903-9FEB-680FF194FF13Q42237404-65A290A8-5956-4670-82B8-E8BC5887DE77Q43266789-02182479-DE79-45A2-AB97-D92C051B1F0DQ45120298-0F5DB24B-2913-47C6-B7F2-956498403EFBQ45413952-54F436E1-DE5F-4EDB-A084-269ED9754197Q45805245-8B6549A7-4338-4AC1-83E4-70846F21A452Q47808903-A4564813-8D3B-4C3E-94E1-0F2377C07868Q50152400-51AFF6A0-A204-4CA0-BE98-509D79C373D9Q51327416-3907BB7A-1DB7-4481-8E86-65AB1F7392C3Q51693936-38B56D07-058E-43B9-BBB5-77D175E5CE2DQ54291121-050280E8-2302-4DB9-9C81-080816C23207Q56976116-251918EA-20F9-4EA7-8AC4-D8A17B56A5F2Q57588216-6E2771A7-FA35-4272-8069-F7EFE918102CQ58420797-7A6348C4-2578-48AC-8C59-23882B3C306AQ58420809-40B03DD3-CC43-42B8-BCB3-595D034A51CFQ58420933-6D6A172C-2E1C-42FC-A57E-ECAC705F47A0Q58421097-83656D0B-7908-4804-A007-D924874EC1B1Q61713466-000D248B-B216-40F6-BA42-FB777E93A7C0Q61713473-6C7F9F04-4188-49B9-A35A-439C95CD5AB9Q61714872-D3393F2F-A877-4416-B35A-BBF3A00B8C7A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrea Finocchi
@ast
Andrea Finocchi
@en
Andrea Finocchi
@es
Andrea Finocchi
@nl
type
label
Andrea Finocchi
@ast
Andrea Finocchi
@en
Andrea Finocchi
@es
Andrea Finocchi
@nl
prefLabel
Andrea Finocchi
@ast
Andrea Finocchi
@en
Andrea Finocchi
@es
Andrea Finocchi
@nl
P106
P1153
6507801632
P31
P496
0000-0003-0958-8536